Chemiluminescence Immunoassay (CLIA) Analyzers Market
Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis by Analyzers, Reagents, and Consumables from 2023 to 2033
Analysis of Chemiluminescence Immunoassay (CLIA) Analyzers Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Chemiluminescence Immunoassay (CLIA) Analyzers Market Outlook (2023 to 2033)
Expanding at a CAGR of 6.5%, the global chemiluminescence immunoassay (CLIA) analyzers market is estimated to increase from a valuation of US$ 6.4 billion in 2023 to US$ 12 billion by the end of 2033
Hospitals are preferred by patients leading to high demand for chemiluminescence immunoassay solutions in hospital settings, besides the rise in hospital visits as a result of the growing incidence of infectious diseases.
The definition of chemiluminescence is the emission of light during a chemical process without the major production of heat. The term "chemiluminescence immunoassay analyzer" refers to a type of light detector designed specifically to measure the development of antigen-antibody complexes via light emission.
The surging prevalence of chronic and acute diseases, new developments in chemiluminescence immunoassay analyzers, and the growing specificity of CLIA analyzers are contributing to market expansion. Chemiluminescence immunoassay techniques are widely used to detect chronic diseases such as cancer, diabetes, obesity, and autoimmune diseases as well as cardiovascular and infectious diseases.
CLIA is also used by several academic and pharmaceutical establishments to monitor therapeutic drugs. Major market drivers include pharmaceutical companies' increased efforts to identify and develop new medications as well as the growing awareness of early detection of chronic diseases.
One of the main factors propelling the market growth is the widespread use of CLIA analyzers in numerous applications, including endocrinology and oncology, hepatitis and retroviruses, cardiac indications, auto-immune illnesses, bone and mineral disorders, and others. The rapid adoption of advanced immunoassay analyzers, technological advancements in disease diagnosis, and huge demand for preventive diagnosis and treatment monitoring are driving market growth.
Moreover, large-scale laboratories are taking advantage of quality and service constraints faced by small and mid-volume laboratories to capture a larger share of the market using CLIA techniques. International conglomerates operating in clinical labs are expanding their base through mergers and acquisitions in emerging markets. The consolidation among laboratories is resulting in rising test volumes, leading to the rising adoption of complete laboratory automation and integration.
The requirement for higher levels of international certification and result in comparability when using high throughput automated immunoassays is anticipated to drive the market for chemiluminescence immunoassay analyzers. Key market players are concentrating on the creation and introduction of advanced CLIA solutions. The market is being supported by industry players' investments in R&D activities to create and promote new products to meet these demands.
Report Attributes |
Details |
|
Chemiluminescence Immunoassay Analyzers Market Size (2023) |
US$ 6.4 Billion |
|
Projected Market Value (2033) |
US$ 12 Billion |
|
Global Market Growth Rate (2023 to 2033) |
6.5% CAGR |
|
Market Share of Reagents |
50% |
|
Key Companies Profiled |
|
Why are Sales of Chemiluminescence Immunoassay Analyzers Increasing Rapidly across the World?
“Surging Adoption of High Throughput Automated Immunoassay Analyzers”
The increasing rate of assay standardization is a primary emphasis of doctors and pathologists working in in-patient or out-patient settings of the chemiluminescence immunoassay analyzers market. When providing test results to patients, the major goal of calibrating the assays is to compare the results of the test to the accepted standards.
Chemiluminescence immunoassay analyzers are produced according to standards established by regulatory bodies. To make their results more comparable to those of other manual assay techniques, chemiluminescence immunoassay analyzer manufacturers also provide internal reference standard material.
The chemiluminescence immunoassay approach is widely used in the field of clinical diagnostics to identify chronic diseases. The primary global causes of disability and death are these chronic illnesses. The prevalence of these diseases is significantly increasing, which is projected to increase demand for efficient diagnostic techniques such as chemiluminescence immunoassay.
“Rapid Innovations in Diagnostic Technology”
The field of diagnostics is developing quickly, and in the past ten years, significant strides have been made in the identification of antibodies, moving this field of diagnosis closer to that of an automated clinical chemistry laboratory. It is predicted that as a result of technological advancements in illness diagnosis, an increase in demand for treatment monitoring, and the need for preventative diagnosis, several tests are extensively utilizing chemiluminescence immunoassay analyzers.
There is a growing need for high-throughput facilities. Additionally, large-scale laboratories are using chemiluminescence immunoassay procedures to gain market share by taking advantage of the service and quality challenges faced by small and mid-volume laboratories.
Assays or tests that are suggested to assist healthcare professionals in making treatment decisions for patients based on the best response to therapy are known as companion diagnostics. The potential exists to significantly alter the drug development process and commercialize drug candidates by producing safe medications with increased therapeutic effectiveness rapidly and affordably through the co-creation of companion diagnostics and therapeutic products.
The market for companion diagnostics is anticipated to exhibit a significant growth potential due to an increase in the need for specialized therapies and safer medications.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What May Slightly Affect the Global Demand for Chemiluminescence Immunoassay Analyzers?
“Lack of Qualified Medical Experts and Strict Government Regulations”
The lack of qualified labor and medical experts, as well as the strict government regulations may limit the market expansion. High setup cost of chemiluminescence immunoassay analyzers is restraining market growth, according to pricing trends.
Local firms with extensive distribution networks have increased market penetration as a result of the availability of products at relatively lower average selling prices in some geographic areas. This is putting pressure on prices for big manufacturers. There are innovative options available that are comparatively less expensive per treatment, which is also having an impact on the chemiluminescence immunoassay analyzers market growth.
-analyzers-market-forecast-2023-2033.jpg)
Which Regional Market is Catching the Attention of Chemiluminescence Immunoassay Analyze Suppliers?
“High use of Automated CLIA Analyzers in North America”
North America accounts for 50% share of the global chemiluminescence immunoassay analyzers market. Rise in the demand for specific diagnoses to support rapid decision-making is boosting the demand for multiplexed and automated CLIA analyzers. An increase in government funding for chemiluminescence immunoassay-related R&D activities is also anticipated to propel the regional market.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
What Allows the United States to Hold a Significant Share of the Global Market?
“Increasing Need for Appropriate Diagnosis & Treatment Techniques in the Country”
The chemiluminescence immunoassay analyzers market in the United States is anticipated to experience rapid growth due to strong demand for point-of-care, home healthcare, and quick diagnostic tests and the presence of top chemiluminescence immunoassay analyzer manufacturers and suppliers. The existence of well-developed healthcare infrastructure and the rising incidence of chronic diseases are key factors driving market growth.
More than 1 million Americans are coping with melanoma, according to the American Academy of Dermatology Association. As a result, there is a growing need for appropriate diagnosis and treatment techniques, which has led to an increase in the usage of chemiluminescence immunoassay procedures.
What is Driving Chemiluminescence Immunoassay Analyzer Demand in Germany?
“Increase in Government Initiatives for Early Identification of Chronic Diseases”
Increased prevalence of cardiovascular diseases, the revolution in test offerings, rising physician demand for advanced diagnostic instruments with increased specificity & precision, and favorable reimbursement policies are the elements boosting market value in Germany.
The existence of multispecialty hospitals, well-established supply chain management network, and an increase in government initiatives for early identification of various chronic diseases driving market growth in Germany.
What are the Growth Prospects for Chemiluminescence Immunoassay Analyzers in Japan?
“Huge Demand for Medical Testing Services”
The market in Japan is anticipated to be driven by the huge population base, rising disposable income, and growing awareness of early diagnosis & treatment choices among patients. Local supply of novel products comprising CLIA technologies, increased healthcare expenditure, huge demand for medical testing services, and national and international accreditations to establish new laboratories are fueling market expansion in Japan.
Category-wise Insights
Why are Reagents Exhibiting High Demand Growth?
“Reagents Gaining Traction Due to Their Lower Cost & Shorter Test Time”
Based on product, the market is divided into analyzers, reagents, and consumables. Reagents account for 50% share of the global market attributed to their lower cost, shorter test time, and increasing demand from emerging markets. Reagents are substances or compounds that assist in performing a certain operation.
Reagents can be divided into four major categories based on how they perform their respective tasks, including amplification, detection, labeling, and quantification kits. The demand for reagents is anticipated to be driven by the increased development of new testing options, greater accuracy and quality, and a rising need for ultra-sensitive illness diagnosis.
Which Application Will Bring in High Revenue Streams?
“Rising Prevalence of Cancer and Need for Early Diagnosis Driving Adoption of CLIA Analyzers in Oncology”
The market is divided into endocrine disorders, oncology, infectious diseases, hepatitis & retrovirus, cardiovascular disorders, allergy, autoimmunity, drug discovery & development, and others based on application. Rising prevalence of cancer and its early diagnosis driving the adoption of chemiluminescence immunoassay analyzers in oncology.
The R&D for the detection, diagnosis, and treatment of the disease is prompted by the rising incidence of cancer cases worldwide. The development of cancer therapy and detection methods continues to be a top priority for researchers and scientists because it is one of the most widely diagnosed rare diseases.
Demand for chemiluminescence immunoassay analyzers for oncology studies is increasing. Several studies have revealed that the application of novel and confirmed biomarkers can result in the early detection of various malignancies. This is anticipated to stimulate segment expansion.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Top chemiluminescence immunoassay analyzer providers are focused on obtaining regulatory clearances, enhancing product standards, and acquiring other businesses. These tactics are supporting market expansion.
Leading companies are introducing next-generation integrated immunoassay analyzers following safety regulations to lower the environmental impact. Prominent vendors are focusing on quality control and actively expanding their test offerings through ongoing research and development initiatives.
For instance :
- Abbott announced the FDA 510(k) clearance for Alinity ci-series instruments for immunoassay diagnostics. Earlier, the company also announced the approval of its Atellica Solutions for clinical chemistry and immunoassays.
- The latest advanced tissue staining platform, the BenchMark ULTRA PLUS system, was introduced by Roche. With particular immunohistochemistry, immunocytochemistry, or in situ hybridization reagents, the BenchMark ULTRA PLUS device is designed to automatically stain histological or cytological specimens on microscope slides for in vitro diagnostic (IVD) application.
- Beckman Coulter, Inc. offers various immunoassay systems under the clinical products segment. These include the Access 2 Immunoassay System and the UniCel Dxl 600 Access Immunoassay System.
- F. Hoffmann La Roche Ltd. offers clinical chemistry and immunology analyzers and assays for small, medium, and large-scale laboratories. Its products include the cobas4000 analyzer series, the cobas6000 analyzer series, and the cobas8000 modular analyzer series.
Key Segments of Chemiluminescence Immunoassay Analyzers Industry Research
-
By Product :
- Analyzers
- Fully-automated
- Semi-automated
- Reagents
- Luminophore Markers
- Enzymatic Markers
- Consumables
- Analyzers
-
By Application :
- Endocrine Disorders
- Oncology
- Infectious Diseases
- Hepatitis & Retrovirus
- Cardiovascular Disorders
- Allergy
- Autoimmunity
- Drug Discovery & Development
- Others
-
By End User :
- Hospitals
- Clinical Laboratories
- Pharmaceutical & Biological Industries
- Others
-
By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Content
1. Preface 1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Market 4. Market Overview 4.1. Introduction 4.1.1. Product Type Definition 4.1.2. Industry Evolution / Developments 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.1.1. Ultrasensitive method with wider dynamic range of tests 4.3.1.2. Growing demand for international accreditations and result comparability using high throughput automated immunoassays 4.3.2. Restraints 4.3.2.1. Availability of alternative diagnostic test at relatively lower cost 4.3.2.2. Fragmented consumables market affecting profit margin 4.3.3. Opportunity 4.4. Global Market Analysis and Forecasts, 2023–2033 4.4.1. Market Revenue Projections (US$ Mn) 4.5. Market Outlook 4.6. Disease Prevalence & Incidence Rate globally with key countries 4.7. Technological Advancements 4.8. Top 3 players operating in the market space 4.9. Healthcare Industry Overview 5. Global Market Analysis and Forecasts, By Product Type 5.1. Introduction & Definition 5.2. Key Findings / Developments 5.3. Market Value Forecast By Product Type, 2023–2033 5.3.1. Analyzers 5.3.1.1. Automated 5.3.1.2. Semi-automated 5.3.2. Reagents 5.3.2.1. Luminophore Markers 5.3.2.2. Enzymatic Markers 5.3.3. Consumables 5.4. Market Attractiveness By Product Type 6. Global Market Analysis and Forecasts, By Application 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast By Application, 2023–2033 6.3.1. Endocrine Disorders 6.3.2. Oncology 6.3.3. Infectious Diseases 6.3.4. Hepatitis and Retrovirus 6.3.5. Cardiovascular Disorders 6.3.6. Allergy 6.3.7. Autoimmunity 6.3.8. Drug Discovery and Development 6.3.9. Others 6.4. Market Attractiveness By Application 7. Global Market Analysis and Forecasts, By End-user 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast By End-user, 2023–2033 7.3.1. Hospitals 7.3.2. Clinical Laboratories 7.3.3. Pharmaceutical & Biotechnology Industries 7.3.4. Others 7.4. Market Attractiveness By End-user 8. Global Market Analysis and Forecasts, By Region 8.1. Key Findings 8.2. Market Value Forecast By Region 8.2.1. North America 8.2.2. Europe 8.2.3. Asia Pacific 8.2.4. Latin America 8.2.5. Middle East & Africa 8.3. Market Attractiveness By Country/Region 9. North America Market Analysis and Forecast 9.1. Introduction 9.1.1. Key Findings 9.2. Market Value Forecast By Product Type, 2023–2033 9.2.1. Analyzers 9.2.1.1. Automated 9.2.1.2. Semi-automated 9.2.2. Reagents 9.2.2.1. Luminophore Markers 9.2.2.2. Enzymatic Markers 9.2.3. Consumables 9.3. Market Value Forecast By Application, 2023–2033 9.3.1. Endocrine Disorders 9.3.2. Oncology 9.3.3. Infectious Diseases 9.3.4. Hepatitis and Retrovirus 9.3.5. Cardiovascular Disorders 9.3.6. Allergy 9.3.7. Autoimmunity 9.3.8. Drug Discovery and Development 9.3.9. Others 9.4. Market Value Forecast By End-user, 2023–2033 9.4.1. Hospitals 9.4.2. Clinical Laboratories 9.4.3. Pharmaceutical & Biotechnology Industries 9.4.4. Others 9.5. Market Value Forecast By Country, 2023–2033 9.5.1. U.S. 9.5.2. Canada 9.6. Market Attractiveness Analysis 9.6.1. By Product Type 9.6.2. By Application 9.6.3. By End-user 9.6.4. By Country 10. Europe Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.2. Market Value Forecast By Product Type, 2023–2033 10.2.1. Analyzers 10.2.1.1. Automated 10.2.1.2. Semi-automated 10.2.2. Reagents 10.2.2.1. Luminophore Markers 10.2.2.2. Enzymatic Markers 10.2.3. Consumables 10.3. Market Value Forecast By Application, 2023–2033 10.3.1. Endocrine Disorders 10.3.2. Oncology 10.3.3. Infectious Diseases 10.3.4. Hepatitis and Retrovirus 10.3.5. Cardiovascular Disorders 10.3.6. Allergy 10.3.7. Autoimmunity 10.3.8. Drug Discovery and Development 10.3.9. Others 10.4. Market Value Forecast By End-user, 2023–2033 10.4.1. Hospitals 10.4.2. Clinical Laboratories 10.4.3. Pharmaceutical & Biotechnology Industries 10.4.4. Others 10.5. Market Value Forecast By Country/Sub-region, 2023–2033 10.5.1. Germany 10.5.2. U.K. 10.5.3. France 10.5.4. Spain 10.5.5. Italy 10.5.6. Rest of Europe 10.6. Market Attractiveness Analysis 10.6.1. By Product Type 10.6.2. By Application 10.6.3. By End-user 10.6.4. By Country/Sub-region 11. Asia Pacific Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast By Product Type, 2023–2033 11.2.1. Analyzers 11.2.1.1. Automated 11.2.1.2. Semi-automated 11.2.2. Reagents 11.2.2.1. Luminophore Markers 11.2.2.2. Enzymatic Markers 11.2.3. Consumables 11.3. Market Value Forecast By Application, 2023–2033 11.3.1. Endocrine Disorders 11.3.2. Oncology 11.3.3. Infectious Diseases 11.3.4. Hepatitis and Retrovirus 11.3.5. Cardiovascular Disorders 11.3.6. Allergy 11.3.7. Autoimmunity 11.3.8. Drug Discovery and Development 11.3.9. Others 11.4. Market Value Forecast By End-user, 2023–2033 11.4.1. Hospitals 11.4.2. Clinical Laboratories 11.4.3. Pharmaceutical & Biotechnology Industries 11.4.4. Others 11.5. Market Value Forecast By Country/Sub-region, 2023–2033 11.5.1. China 11.5.2. Japan 11.5.3. India 11.5.4. Australia & New Zealand 11.5.5. Rest of Asia Pacific 11.6. Market Attractiveness Analysis 11.6.1. By Product Type 11.6.2. By Application 11.6.3. By End-user 11.6.4. By Country/Sub-region 12. Latin America Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast By Product Type, 2023–2033 12.2.1. Analyzers 12.2.1.1. Automated 12.2.1.2. Semi-automated 12.2.2. Reagents 12.2.2.1. Luminophore Markers 12.2.2.2. Enzymatic Markers 12.2.3. Consumables 12.3. Market Value Forecast By Application, 2023–2033 12.3.1. Endocrine Disorders 12.3.2. Oncology 12.3.3. Infectious Diseases 12.3.4. Hepatitis and Retrovirus 12.3.5. Cardiovascular Disorders 12.3.6. Allergy 12.3.7. Autoimmunity 12.3.8. Drug Discovery and Development 12.3.9. Others 12.4. Market Value Forecast By End-user, 2023–2033 12.4.1. Hospitals 12.4.2. Clinical Laboratories 12.4.3. Pharmaceutical & Biotechnology Industries 12.4.4. Others 12.5. Market Value Forecast By Country/Sub-region, 2023–2033 12.5.1. Brazil 12.5.2. Mexico 12.5.3. Rest of Latin America 12.6. Market Attractiveness Analysis 12.6.1. By Product Type 12.6.2. By Application 12.6.3. By End-user 12.6.4. By Country/Sub-region 13. Middle East & Africa Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast By Product Type, 2023–2033 13.2.1. Analyzers 13.2.1.1. Automated 13.2.1.2. Semi-automated 13.2.2. Reagents 13.2.2.1. Luminophore Markers 13.2.2.2. Enzymatic Markers 13.2.3. Consumables 13.3. Market Value Forecast By Application, 2023–2033 13.3.1. Endocrine Disorders 13.3.2. Oncology 13.3.3. Infectious Diseases 13.3.4. Hepatitis and Retrovirus 13.3.5. Cardiovascular Disorders 13.3.6. Allergy 13.3.7. Autoimmunity 13.3.8. Drug Discovery and Development 13.3.9. Others 13.4. Market Value Forecast By End-user, 2023–2033 13.4.1. Hospitals 13.4.2. Clinical Laboratories 13.4.3. Pharmaceutical & Biotechnology Industries 13.4.4. Others 13.5. Market Value Forecast By Country/Sub-region, 2023–2033 13.5.1. GCC Countries 13.5.2. South Africa 13.5.3. Israel 13.5.4. Rest of Middle East & Africa 13.6. Market Attractiveness Analysis 13.6.1. By Product Type 13.6.2. By Application 13.6.3. By End-user 13.6.4. By Country/Sub-region 14. Competition Landscape 14.1. Market Player – Competition Matrix (By Tier and Size of companies) 14.2. Market Share Analysis By Company (2022) 14.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy) 14.3.1. Abbott 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strengths) 14.3.1.2. Financial Overview 14.3.1.3. Product Portfolio 14.3.1.4. SWOT Analysis 14.3.1.5. Strategic Overview 14.3.2. F. Hoffmann-La Roche Ltd 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strengths) 14.3.2.2. Financial Overview 14.3.2.3. Product Portfolio 14.3.2.4. SWOT Analysis 14.3.2.5. Strategic Overview 14.3.3. Siemens Healthcare GmbH (Siemens AG) 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strengths) 14.3.3.2. Financial Overview 14.3.3.3. Product Portfolio 14.3.3.4. SWOT Analysis 14.3.3.5. Strategic Overview 14.3.4. Danaher (Beckman Coulter, Inc.) 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strengths) 14.3.4.2. Financial Overview 14.3.4.3. Product Portfolio 14.3.4.4. SWOT Analysis 14.3.4.5. Strategic Overview 14.3.5. DiaSorin S.p.A. 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strengths) 14.3.5.2. Financial Overview 14.3.5.3. Product Portfolio 14.3.5.4. SWOT Analysis 14.3.5.5. Strategic Overview 14.3.6. Ortho Clinical Diagnostics (Part of Carlyle Group) 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strengths) 14.3.6.2. Financial Overview 14.3.6.3. Product Portfolio 14.3.6.4. SWOT Analysis 14.3.6.5. Strategic Overview 14.3.7. Shenzhen New Industries Biomedical Engineering Co., Ltd. 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strengths) 14.3.7.2. Financial Overview 14.3.7.3. Product Portfolio 14.3.7.4. SWOT Analysis 14.3.7.5. Strategic Overview 14.3.8. Sysmex Corporation 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strengths) 14.3.8.2. Financial Overview 14.3.8.3. Product Portfolio 14.3.8.4. SWOT Analysis 14.3.8.5. Strategic Overview 14.3.9. Randox Laboratories Ltd. 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strengths) 14.3.9.2. Financial Overview 14.3.9.3. Product Portfolio 14.3.9.4. SWOT Analysis 14.3.9.5. Strategic Overview 14.3.10. Tosoh Corporation 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strengths) 14.3.10.2. Financial Overview 14.3.10.3. Product Portfolio 14.3.10.4. SWOT Analysis
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Forecast, by Product, 2023–2033
Table 02: Global Market Value (US$ Mn) Forecast, by Analyzers, 2023–2033
Table 03: Global Market Value (US$ Mn) Forecast, by Reagents, 2023–2033
Table 04: Global Market Value (US$ Mn) Forecast, by Application, 2023–2033
Table 05: Global Market Value (US$ Mn) Forecast, by End-user, 2023–2033
Table 06: Global Market Size (US$ Mn) Forecast, by Region, 2023–2033
Table 07: North America Market Value (US$ Mn) Forecast, by Country, 2023–2033
Table 08: North America Market Value (US$ Mn) Forecast, by Product, 2023–2033
Table 09: North America Market Value (US$ Mn) Forecast, by Analyzers, 2023–2033
Table 10: North America Market Value (US$ Mn) Forecast, by Reagents, 2023–2033
Table 11: North America Market Value (US$ Mn) Forecast, by Application, 2023–2033
Table 12: North America Market Value (US$ Mn) Forecast, by End-user, 2023–2033
Table 13: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033
Table 14: Europe Market Value (US$ Mn) Forecast, by Product, 2023–2033
Table 15: Europe Market Value (US$ Mn) Forecast, by Analyzers, 2023–2033
Table 16: Europe Market Value (US$ Mn) Forecast, by Reagents, 2023–2033
Table 17: Europe Market Value (US$ Mn) Forecast, by Application, 2023–2033
Table 18: Europe Market Value (US$ Mn) Forecast, by End-user, 2023–2033
Table 19: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033
Table 20: Asia Pacific Market Value (US$ Mn) Forecast, by Product, 2023–2033
Table 21: Asia Pacific Market Value (US$ Mn) Forecast, by Analyzers, 2023–2033
Table 22: Asia Pacific Market Value (US$ Mn) Forecast, by Reagents, 2023–2033
Table 23: Asia Pacific Market Value (US$ Mn) Forecast, by Application, 2023–2033
Table 24: Asia Pacific Market Value (US$ Mn) Forecast, by End-user, 2023–2033
Table 25: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033
Table 26: Latin America Market Value (US$ Mn) Forecast, by Product, 2023–2033
Table 27: Latin America Market Value (US$ Mn) Forecast, by Analyzers, 2023–2033
Table 28: Latin America Market Value (US$ Mn) Forecast, by Reagents, 2023–2033
Table 29: Latin America Market Value (US$ Mn) Forecast, by Application, 2023–2033
Table 30: Latin America Market Value (US$ Mn) Forecast, by End-user, 2023–2033
Table 31: Middle East & Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033
Table 32: Middle East & Africa Market Value (US$ Mn) Forecast, by Product, 2023–2033
Table 33: Middle East & Africa Market Value (US$ Mn) Forecast, by Analyzers, 2023–2033
Table 34: Middle East & Africa Market Value (US$ Mn) Forecast, by Reagents, 2023–2033
Table 35: Middle East & Africa Market Value (US$ Mn) Forecast, by Application, 2023–2033
Table 36: Middle East & Africa Market Value (US$ Mn) Forecast, by End-user, 2023–2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2033
Figure 02: Global Market Value (US$ Mn) Forecast, 2023–2033
Figure 03: Global Market Value Share, by Product (2022)
Figure 04: Global Market Value Share, by Application (2022)
Figure 05: Global Market Value Share, by End-user (2022)
Figure 06: Global Market Value Share, by Region (2022)
Figure 07: Global Market Value Share, by Product, 2023 and 2033
Figure 08: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection
Figure 09: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection
Figure 10: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection
Figure 11: Global Market Attractiveness, by Product, 2023–2033
Figure 12: Global Market Value Share, by Application, 2023 and 2033
Figure 13: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection
Figure 14: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection
Figure 15: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection
Figure 16: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection
Figure 17: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
Figure 18: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection
Figure 19: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
Figure 20: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection
Figure 21: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection
Figure 22: Global Market Attractiveness, by Application, 2023–2033
Figure 23: Global Market Value Share, by End-user, 2023 and 2033
Figure 24: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection
Figure 25: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection
Figure 26: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection
Figure 27: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection
Figure 28: Global Market Attractiveness, by End-user, 2023–2033
Figure 29: Global Market Value Share, by Region, 2023 and 2033
Figure 30: Global Market Attractiveness, by Region, 2023–2033
Figure 31: North America Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection
Figure 32: North America Market Value Share, by Country, 2023 and 2033
Figure 33: North America Market Attractiveness, by Country, 2023–2033
Figure 34: North America Market Value Share, by Product, 2023 and 2033
Figure 35: North America Market Attractiveness, by Product, 2023–2033
Figure 36: North America Market Value Share, by Application, 2023 and 2033
Figure 37: North America Market Attractiveness, by Application, 2023–2033
Figure 38: North America Market Value Share, by End-user, 2023 and 2033
Figure 39: North America Market Attractiveness, by End-user, 2023–2033
Figure 40: Europe Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection
Figure 41: Europe Market Value Share, by Country/Sub-region, 2023 and 2033
Figure 42: Europe Market Attractiveness, by Country/Sub-region, 2023–2033
Figure 43: Europe Market Value Share, by Product, 2023 and 2033
Figure 44: Europe Market Attractiveness, by Product, 2023–2033
Figure 45: Europe Market Value Share, by Application, 2023 and 2033
Figure 46: Europe Market Attractiveness, by Application, 2023–2033
Figure 47: Europe Market Value Share, by End-user, 2023 and 2033
Figure 48: Europe Market Attractiveness, by End-user, 2023–2033
Figure 49: Asia Pacific Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection
Figure 50: Asia Pacific Market Value Share, by Country/Sub-region, 2023 and 2033
Figure 51: Asia Pacific Market Attractiveness, by Country/Sub-region, 2023–2033
Figure 52: Asia Pacific Market Value Share, by Product, 2023 and 2033
Figure 53: Asia Pacific Market Attractiveness, by Product, 2023–2033
Figure 54: Asia Pacific Market Value Share, by Application, 2023 and 2033
Figure 55: Asia Pacific Market Attractiveness, by Application, 2023–2033
Figure 56: Asia Pacific Market Value Share, by End-user, 2023 and 2033
Figure 57: Asia Pacific Market Attractiveness, by End-user, 2023–2033
Figure 58: Latin America Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection
Figure 59: Latin America Market Value Share, by Country/Sub-region, 2023 and 2033
Figure 60: Latin America Market Attractiveness, by Country/Sub-region, 2023–2033
Figure 61: Latin America Market Value Share, by Product, 2023 and 2033
Figure 62: Latin America Market Attractiveness, by Product, 2023–2033
Figure 63: Latin America Market Value Share, by Application, 2023 and 2033
Figure 64: Latin America Market Attractiveness, by Application, 2023–2033
Figure 65: Latin America Market Value Share, by End-user, 2023 and 2033
Figure 66: Latin America Market Attractiveness, by End-user, 2023–2033
Figure 67: Middle East & Africa Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection
Figure 68: Middle East & Africa Market Value Share, by Country/Sub-region, 2023 and 2033
Figure 69: Middle East & Africa Market Attractiveness, by Country/Sub-region, 2017– 2033
Figure 70: Middle East & Africa Market Value Share, by Product, 2023 and 2033
Figure 71: Middle East & Africa Market Attractiveness, by Product, 2023–2033
Figure 72: Middle East & Africa Market Value Share, by Application, 2023 and 2033
Figure 73: Middle East & Africa Market Attractiveness, by Application, 2023–2033
Figure 74: Middle East & Africa Market Value Share, by End-user, 2023 and 2033
Figure 75: Middle East & Africa Market Attractiveness, by End-user, 2023–2033
Figure 76: Global Market Share, by Company, 2022
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the current global market size for chemiluminescence immunoassay analyzers?
The global CLIA analyzers market is valued at US$ 6.4 billion in 2023.
What is the predicted growth rate for the CLIA analyzers market?
Global adoption of chemiluminescence immunoassay analyzers is estimated to rise at a CAGR of 6.5% through 2033.
Which product holds a prominent share of the global market?
Currently, reagents account for 50% share of the global market.
What is boosting the demand for chemiluminescence immunoassay analyzers?
Increasing prevalence of chronic diseases due to changing lifestyles and unhealthy eating habits is driving market expansion.
Who are the key producers of chemiluminescence immunoassay analyzers?
Abbott Laboratories, Beckman Coulter, Inc., and Roche Holding AG are the top providers of chemiluminescence immunoassay analyzers.
Chemiluminescence Immunoassay (CLIA) Analyzers Market